138 related articles for article (PubMed ID: 37700831)
1. Impact of HR-HPV infection on oncological outcomes in early cervical cancer.
Su X; Liu P; Zhao H; Sun L; Wang W; Jin S; Wang H; Liu P; Chen C; Hao M
Front Oncol; 2023; 13():1264114. PubMed ID: 37700831
[TBL] [Abstract][Full Text] [Related]
2. [Long-term oncological outcomes of laparoscopic versus abdominal surgery in stage Ⅰa1 （LVSI
Chen CL; Kang S; Chen BL; Yang Y; Guo JX; Hao M; Wang WL; Ji M; Sun LX; Wang L; Liang WT; Wang SG; Li WL; Fan HJ; Liu P; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2020 Sep; 55(9):589-599. PubMed ID: 32957747
[No Abstract] [Full Text] [Related]
3. Comparison of the Oncological Outcomes Between Robot-Assisted and Abdominal Radical Hysterectomy for Cervical Cancer Based on the New FIGO 2018 Staging System: A Multicentre Retrospective Study.
Li P; Zhan X; Lv C; Lin Z; Yang Y; Wang W; Wang S; Hao M; Zhu B; Bin X; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():879569. PubMed ID: 35847917
[TBL] [Abstract][Full Text] [Related]
4. Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals.
Liu P; Lin L; Kong Y; Huo Z; Zhu L; Bin X; Lang J; Chen C
BMC Cancer; 2020 Mar; 20(1):189. PubMed ID: 32138718
[TBL] [Abstract][Full Text] [Related]
5. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
[No Abstract] [Full Text] [Related]
6. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract][Full Text] [Related]
7. Hazard Ratio Analysis of Laparoscopic Radical Hysterectomy for IA1 With LVSI-IIA2 Cervical Cancer: Identifying the Possible Contraindications of Laparoscopic Surgery for Cervical Cancer.
Li P; Liu P; Yang Y; Wang L; Liu J; Bin X; Lang J; Chen C
Front Oncol; 2020; 10():1002. PubMed ID: 32733796
[No Abstract] [Full Text] [Related]
8. Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer.
Chen C; Guo J; Liu P; Li Z; Jiang H; Zhu Q; Bin X; Lang J
J Obstet Gynaecol Res; 2021 Apr; 47(4):1516-1526. PubMed ID: 33527615
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcomes of Patients With Stage IB3 Cervical Cancer Who Undergo Abdominal Radical Hysterectomy Versus Radiochemotherapy.
Li Z; Yang Q; Guo J; Liang G; Duan H; Wang S; Hao M; Liang W; Li D; Zhan X; Xie Q; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():933755. PubMed ID: 35875125
[TBL] [Abstract][Full Text] [Related]
10. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
[TBL] [Abstract][Full Text] [Related]
11. [Effects of colpotomic approaches on prognosis and recurrence sites of stage Ⅰa2-Ⅱa2 cervical cancer after laparoscopic radical hysterectomy].
Zhou D; Li YD; Ling KJ; Wang RW; Wang YZ; Tang S; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2023 Jan; 58(1):49-59. PubMed ID: 36720615
[No Abstract] [Full Text] [Related]
12. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
13. Independent prognostic role of human papillomavirus genotype in cervical cancer.
Hang D; Jia M; Ma H; Zhou J; Feng X; Lyu Z; Yin J; Cui H; Yin Y; Jin G; Hu Z; Shen H; Zhang K; Li N; Dai M
BMC Infect Dis; 2017 Jun; 17(1):391. PubMed ID: 28583086
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China.
He J; Li D; Shen P; Liang W; Kang S; Zhang Y; Zhao H; Liu M; Wang X; Lin Z; Bin X; Lang J; Liu P; Chen C
Int J Clin Oncol; 2022 Mar; 27(3):619-625. PubMed ID: 34837596
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients.
Chen Q; Shi R; Liu Z; Shi Z; Gu K; Chen J; He Y; Li Y; Wu J; Ji S; Zhou J; Zhu J
J Cancer; 2020; 11(20):5911-5917. PubMed ID: 32922533
[No Abstract] [Full Text] [Related]
16. Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
Chen B; Ji M; Li P; Liu P; Zou W; Zhao Z; Qu B; Li Z; Bin X; Lang J; Wang H; Chen C
Gynecol Oncol; 2020 May; 157(2):429-436. PubMed ID: 32067814
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer.
Jiang Y; Gu H; Zheng X; Pan B; Liu P; Zheng M
Pathol Oncol Res; 2021; 27():1609946. PubMed ID: 34992504
[No Abstract] [Full Text] [Related]
18. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
[TBL] [Abstract][Full Text] [Related]
19. Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract][Full Text] [Related]
20. Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018).
Chen X; Liang W; Duan H; Wu M; Zhan X; Dai E; Lv Q; Xie Q; Liu R; Xu Y; Bin X; Lang J; Liu P; Chen C
Front Oncol; 2022; 12():800049. PubMed ID: 35494051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
